Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$382,479.00
Agreement Date:
Jan 1, 2013 - Dec 31, 2015
Description:
Neutraceuticals and diabetes: Nrf-2 activation is a critical mechanism underlying the effect of certain plant-derived compounds in preventing insulin resistance.
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 1X5
Reference Number:
236-2012-2013-Q4-00156
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2012-13 to 2015-16)

Recipient's Legal Name:
FANTUS, Ivan G
Research Organization:
Sinai Health System (Toronto)